A Phase I Study to Characterize the Pharmacokinetics of 4 mg/m2 Weekly Intravenous Topotecan in Patients With Cancer
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Topotecan (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from Nov 2006 to Sep 2006 as reported by ClinicalTrials.gov.
- 15 Jan 2008 Status changed from in progress to completed.
- 27 Jul 2007 Status change from recruiting to in progress.